Pentraxin-3 and Outcomes in CKD: A Systematic Review and Meta-analysis

Pentraxin-3 and Outcomes in CKD: A Systematic Review and Meta-analysis

Rationale & Objective: Long pentraxin-3 (PTX-3) serves as a biomarker for prognosticating adverse clinical outcomes in individuals with chronic kidney disease (CKD). The objective of the current meta-analysis was to evaluate the prognostic efficacy of PTX-3 in patients with CKD. In addition,...

Full description

Bibliographic Details
Main Authors:	Li Li, Hongli Liu, Qinglin Zhang, Hao Jin, Hui Tao, Hongmei Chen, Zhongwei Zhou
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney Medicine
Subjects:	Pentraxin-3 C-reactive protein chronic kidney disease adverse outcomes meta-analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059524000116

Similar Items

An interventional study of baicalin on neuronal pentraxin-1, neuronal pentraxin-2, and C-reactive protein in Alzheimer’s disease rat model
by: Zhao Jing-Kun, et al.
Published: (2023-09-01)

A Comparative Study of the Effectiveness of Serum C-reactive Protein and Serum Pentraxin-3 Levels in the Diagnosis and Follow-up of Neonatal Sepsis
by: Tugrul Atay, et al.
Published: (2022-01-01)

The Diagnostic and Assessment Value of Plasma Pentraxin 3 in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Gu Y, et al.
Published: (2023-07-01)

Diagnostic Value of Pentraxin-3 in COVID-19 Pediatric Patients
by: Didem Öcal Topçu, et al.
Published: (2024-09-01)

Association of pentraxin and high-sensitive C-reactive protein as inflammatory biomarkers in patients with chronic periodontitis and peripheral arterial disease
by: Ramanarayana Boyapati, et al.
Published: (2018-01-01)

The assessment of pentraxin 3: a diagnostic and prognostic biomarker in lower respiratory tract infections in children
by: Shaimaa Madkour, et al.
Published: (2024-09-01)

CONTENT OF PENTRAXIN-3 AND C-REACTIVE PROTEIN IN BLOOD SERUM OF CHILDREN AND ADOLESCENTS SUFFERING FROM RESPIRATORY TUBERCULOSIS WITH DESTRUCTION AND MINOR FORMS OF THE DISEASE
by: M. M. Averbakh (J.), et al.
Published: (2016-09-01)

High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy
by: Elodie Bousquet, MD, PhD, et al.
Published: (2023-09-01)

Pentraxin 3: a novel biomarker in pediatric central nervous system infections
by: Huda El-Kady, et al.
Published: (2025-01-01)

Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies
by: Kejun Ding, et al.
Published: (2022-01-01)

Serum pentraxin-3 in patients with chronic obstructive pulmonary disease: A meta-analysis
by: Yan Zhu, et al.
Published: (2024-08-01)

Postoperative kinetics of pentraxin 3 (PTX3) after congenital heart surgery with cardiopulmonary bypass in pediatric patients
by: Radoslaw Jaworski, et al.
Published: (2022-08-01)

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies
by: Eszter Trojnar, et al.
Published: (2019-02-01)

Pentraxin-3 regulates the inflammatory activity of macrophages
by: Aya Shiraki, et al.
Published: (2016-03-01)

The Role of Pentraxin 3 in Aspergillosis: Reality and Prospects
by: Yuening Kang, et al.
Published: (2020-02-01)

Evaluating the Interplay between Pentraxin-3 and Cystatin C in Migraine Patients
by: Maham Tahir, et al.
Published: (2023-10-01)

Studying the interaction of pentraxin-3 with parameters for assessing the course of chronic heart failure in patients with rheumatoid arthritis
by: A.S. Ankudinov, et al.
Published: (2022-02-01)

The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis
by: Rémi Porte, et al.
Published: (2019-04-01)

The utility of pentraxin 3 and platelet-derived growth factor receptor beta as non-invasive biomarkers for prediction of cardiovascular risk in MAFLD patients
by: Hanaa Badran, et al.
Published: (2024-08-01)

Prognostic value of serum pentraxin 3 for intracerebral hemorrhage mortality
by: Pu-Heng Hao, et al.
Published: (2021-03-01)

The Effect of Non-Surgical Periodontal Therapy on Pentraxin-3 Concentration in Gingival Crevicular Fluid of Chronic Periodontitis Patients: A Clinical Trial
by: Asieh Mozaffari, et al.
Published: (2022-09-01)

The role of the inflammatory protein Pentraxin 3 as a biomarker in patients with ischemic heart disease
by: D. Hristov
Published: (2024-12-01)

Targeting the pentraxin 3/CD44 axis: A potential treatment for pulmonary fibrosis
by: Shia Vang, et al.
Published: (2023-02-01)

Pentraxin3 exacerbates acute pancreatitis injury by inhibiting oxidative phosphorylation pathway
by: Wenyue Wang, et al.
Published: (2025-02-01)

Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease
by: Burak Katipoglu, et al.
Published: (2018-12-01)

Serum and urinary pentraxin-3 levels in type 2 diabetes and its relation to diabetic nephropathy
by: Said M Al-Barshomy, et al.
Published: (2018-01-01)

Editorial: Biology of C-reactive protein
by: Alok Agrawal, et al.
Published: (2024-06-01)

Identification and characterization of a novel zebrafish (Danio rerio) pentraxin–carbonic anhydrase
by: Maarit S. Patrikainen, et al.
Published: (2017-12-01)

Does Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy?
by: Vuković-Dejanović Vesna, et al.
Published: (2022-01-01)

Evaluation of pentraxin 3 level and cardiac functions in psoriatic children
by: Mecnun Çetin, et al.
Published: (2020-02-01)

Pentraxin-3 – a promising biological marker in heart failure: literature review
by: Amina M. Alieva, et al.
Published: (2022-01-01)

Association of Plasma Pentraxin-3 Levels on Admission with In-hospital Mortality in Patients with Acute Type A Aortic Dissection
by: Qin Zhou, et al.
Published: (2016-01-01)

Blockade of the pentraxin 3/CD44 interaction attenuates lung injury‐induced fibrosis
by: Jhih‐Ying Chi, et al.
Published: (2022-11-01)

Diagnostic Value of Plasma Pentraxin-3 in Acute Appendicitis
by: Ali Aygun, et al.
Published: (2019-02-01)

Diagnostic Value of Pentraxin-3 in Patients with Spontaneous Subarachnoid and Intracerebral Hemorrhage
by: Can Ertan Argın, et al.
Published: (2017-09-01)

Progress in the study of pentraxin-3(PTX-3) as a biomarker for sepsis
by: Yi Zhang, et al.
Published: (2024-07-01)

Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins
by: Chiara Elisabeth Geyer, et al.
Published: (2021-05-01)

A network meta-analysis of therapies for hyperphosphatemia in CKD based on randomized trials
by: Congyang Zheng, et al.
Published: (2025-01-01)

Serum interleukin-35 and pentraxin-3 levels in patients with mild acute pancreatitis
by: Evrim Aksoy, et al.
Published: (2019-03-01)

Brief Commentary on the Article “Diagnostic Value of Plasma Pentraxin-3 in Acute Appendicitis”
by: Meer Chisthi
Published: (2019-02-01)